| CXSL1400051 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2014-06-27 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2015-04-22 | view |
| CXSL1400057 | 手足口病(EV71型)人免疫球蛋白 | | Other | Biological Products(1) | New Drug Application | 2014-06-27 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2016-04-07 | view |
| CXSL1600021 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2016-05-16 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL2101101 | 人血管性血友病因子 | | Other | Biological Products(3.2) | New Drug Application | 2021-06-02 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
| CXSL2101366 | 静注人免疫球蛋白（10%） | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2021-10-14 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
| CXSL2300226 | C1酯酶抑制剂 | | Injection | Biological Products(3.2) | New Drug Application | 2023-04-05 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
| CXSS1700032 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2018-03-28 | 博雅生物制药集团股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2019-05-20 | view |
| CXSS1900026 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2019-06-27 | 博雅生物制药集团股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2020-12-10 | view |
| CXSS2101006 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2021-07-01 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
| CXSS2400081 | 破伤风人免疫球蛋白 | human tetanus immunoglobulin | Injection | Biological Products(3.4) | New Drug Application | 2024-07-31 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
| CYSB0500046 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2005-04-27 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2005-09-20 | view |
| CYSB0500047 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2005-04-27 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2005-09-09 | view |
| CYSB0500048 | 人血白蛋白 | human albumin | Injection | Biological Products | Supplementary Application | 2005-04-27 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2005-09-09 | view |
| CYSB0600005 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2006-07-11 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2007-11-05 | view |
| CYSB1200311 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2013-04-01 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2013-10-23 | view |
| CYSB1500070 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products | Supplementary Application | 2016-04-15 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2016-10-11 | view |
| CYSB1600254 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products | Supplementary Application | 2017-02-22 | 江西博雅生物制药股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2017-04-17 | view |
| CYSB2000261 | 冻干静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Lyophilized | Biological Products(原15) | Supplementary Application | 2020-11-07 | 博雅生物制药集团股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | In Review | 2020-11-06 | view |
| CYSB2000262 | 冻干静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Lyophilized | Biological Products(原15) | Supplementary Application | 2020-11-07 | 博雅生物制药集团股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | Certificate Issued | 2021-08-27 | view |
| CYSB2000264 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2020-11-07 | 博雅生物制药集团股份有限公司 | China Resources Boya Bio-pharmaceutical Group Co Ltd | In Review | 2020-11-06 | view |
